Chennai Meenakshi Multispeciality Intrinsic Value
Chennai Meenakshi Multispeciality (CMMHOSP) median intrinsic value is ₹37.00 from 2 valuation models (range ₹23–₹37), vs current price ₹37.30 — -0.8% downside (Trading Near Calculated Value), margin of safety -0.8%. Read Chennai Meenakshi Multispecial dividend payments for the complete payout history and dividend yield track record.
CMMHOSP Valuation Methods Summary — DCF, Graham Number & P/E
Chennai Meenakshi Multispeciality intrinsic value across 2 models vs current price ₹37.30 — upside/downside and value range per method. Analyse CMMHOSP shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹37.00 | ₹33.30 - ₹40.70 | -0.8% | Revenue/Share: ₹46.25, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹23.21 | ₹18.57 - ₹27.85 | -37.8% | CF Growth: 5.0%, Discount: 15% |
CMMHOSP Intrinsic Value vs Market Price — All Valuation Models
Chennai Meenakshi Multispeciality fair value range ₹23–₹37 vs current market price ₹37.30 across 2 valuation models. For current market price and key ratios, visit CMMHOSP share price screener.
CMMHOSP Intrinsic Value Analysis — Undervalued or Overvalued?
Chennai Meenakshi Multispeciality median intrinsic value ₹37.00, current price ₹37.30 — Trading Near Calculated Value by 0.8%, margin of safety -0.8%.
What is the intrinsic value of CMMHOSP?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Chennai Meenakshi Multispeciality (CMMHOSP) is ₹37.00 (median value). With the current market price of ₹37.30, this represents a -0.8% variance from our estimated fair value.
The valuation range spans from ₹23.21 to ₹37.00, indicating ₹23.21 - ₹37.00.
Is CMMHOSP undervalued or overvalued?
Based on our multi-method analysis, Chennai Meenakshi Multispeciality (CMMHOSP) appears to be trading near calculated value by approximately 0.8%.
CMMHOSP Financial Health — Key Ratios vs Industry Benchmarks
Chennai Meenakshi Multispeciality financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.67 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 33.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.76x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CMMHOSP Cash Flow Quality — Operating & Free Cash Flow
Chennai Meenakshi Multispeciality operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |